| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Walther Cancer Center, W. M. Keck Center for Transgene Research, and Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556
In vivo tumor progression in mice with targeted deficiencies in urokinase-type plasminogen activator (UPA-/-) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1-/-), was studied using a fibrosarcoma tumor model. Murine T241 fibrosarcoma cells were s.c. implanted into three groups of mice with the following genotypes, wild-type (WT), UPA-/-, and PAI-1-/-. A significantly diminished primary tumor growth in UPA-/- and PAI-1-/- mice occurred, relative to WT mice. Tumors in UPA-/- and PAI-1-/- mice displayed lower proliferative and higher apoptotic indices and displayed a different neovascular morphology, as compared with WT mice. These results are consistent with the decreased growth rates of this tumor in these gene-deleted mice. Immunohistochemical analyses of the tumors revealed a decrease in vascularity and vascular endothelial growth factor expression only in tumors in PAI-1-/- mice. Analyses of the relative extents of corneal angiogenesis in these same animals, induced by basic fibroblast growth factor, corroborated the resistance of PAI-1-/- mice to neovascularization. The results obtained suggest that the host fibrinolytic system plays an important role in tumor growth in this model. Alterations in host expression of components of this system may alter tumor growth and dissemination by affecting the balance between tumor cell death and proliferation, as well as extracellular matrix changes needed for invasiveness and angiogenesis.
This article has been cited by other articles:
|
|
 |
|
  C.M. Maillard, C. Bouquet, M.M. Petitjean, M. Mestdagt, E. Frau, M. Jost, A.M. Masset, P.H. Opolon, F. Beermann, M.M. Abitbol, et al. Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors Carcinogenesis, November 1, 2008; 29(11): 2236 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Chen, D. O. Henry, P. R. Reczek, and M. K.K. Wong Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis Mol. Cancer Ther., May 1, 2008; 7(5): 1227 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jost, C. Maillard, J. Lecomte, V. Lambert, M. Tjwa, P. Blaise, M.-L. Alvarez Gonzalez, K. Bajou, S. Blacher, P. Motte, et al. Tumoral and Choroidal Vascularization: Differential Cellular Mechanisms Involving Plasminogen Activator Inhibitor Type I Am. J. Pathol., October 1, 2007; 171(4): 1369 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Sternlicht, A. M. Dunning, D. H. Moore, P. D.P. Pharoah, D. G. Ginzinger, K. Chin, J. W. Gray, F. M. Waldman, B. A.J. Ponder, and Z. Werb Prognostic Value of PAI1 in Invasive Breast Cancer: Evidence That Tumor-Specific Factors Are More Important Than Genetic Variation in Regulating PAI1 Expression. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2107 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Balsara, F. J. Castellino, and V. A. Ploplis A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial Cells J. Biol. Chem., August 11, 2006; 281(32): 22527 - 22536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, R. C. Budd, R. J. Kelm Jr, B. E. Sobel, and D. J. Schneider Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1 Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Alfano, I. Iaccarino, and M. P. Stoppelli Urokinase Signaling through Its Receptor Protects against Anoikis by Increasing BCL-xL Expression Levels J. Biol. Chem., June 30, 2006; 281(26): 17758 - 17767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Madsen, E. I. Deryugina, S. Niessen, B. F. Cravatt, and J. P. Quigley Activity-based Protein Profiling Implicates Urokinase Activation as a Key Step in Human Fibrosarcoma Intravasation J. Biol. Chem., June 9, 2006; 281(23): 15997 - 16005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax Pericellular Proteases in Angiogenesis and Vasculogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Grum-Schwensen, J. Klingelhofer, C. H. Berg, C. El-Naaman, M. Grigorian, E. Lukanidin, and N. Ambartsumian Suppression of Tumor Development and Metastasis Formation in Mice Lacking the S100A4(mts1) Gene Cancer Res., May 1, 2005; 65(9): 3772 - 3780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yoshida, K. Matsuzaki, S. Mori, Y. Tahashi, H. Yamagata, F. Furukawa, T. Seki, M. Nishizawa, J. Fujisawa, and K. Okazaki Transforming Growth Factor-{beta} and Platelet-Derived Growth Factor Signal via c-Jun N-Terminal Kinase-Dependent Smad2/3 Phosphorylation in Rat Hepatic Stellate Cells after Acute Liver Injury Am. J. Pathol., April 1, 2005; 166(4): 1029 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Paavonen, N. Ekman, M. Wirzenius, I. Rajantie, M. Poutanen, and K. Alitalo Bmx Tyrosine Kinase Transgene Induces Skin Hyperplasia, Inflammatory Angiogenesis, and Accelerated Wound Healing Mol. Biol. Cell, September 1, 2004; 15(9): 4226 - 4233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mayasundari, N. A. Whittemore, E. H. Serpersu, and C. B. Peterson The Solution Structure of the N-terminal Domain of Human Vitronectin: PROXIMAL SITES THAT REGULATE FIBRINOLYSIS AND CELL MIGRATION J. Biol. Chem., July 9, 2004; 279(28): 29359 - 29366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Noel, C Maillard, N Rocks, M Jost, V Chabottaux, N E Sounni, E Maquoi, D Cataldo, and J M Foidart Membrane associated proteases and their inhibitors in tumour angiogenesis J. Clin. Pathol., June 1, 2004; 57(6): 577 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xu, R. D. Balsara, N. V. Gorlatova, D. A. Lawrence, F. J. Castellino, and V. A. Ploplis Conservation of Critical Functional Domains in Murine Plasminogen Activator Inhibitor-1 J. Biol. Chem., April 23, 2004; 279(17): 17914 - 17920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Ploplis, R. Balsara, M. J. Sandoval-Cooper, Z. J. Yin, J. Batten, N. Modi, D. Gadoua, D. Donahue, J. A. Martin, and F. J. Castellino Enhanced in Vitro Proliferation of Aortic Endothelial Cells from Plasminogen Activator Inhibitor-1-deficient Mice J. Biol. Chem., February 13, 2004; 279(7): 6143 - 6151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Palumbo, K. E. Talmage, H. Liu, C. M. La Jeunesse, D. P. Witte, and J. L. Degen Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency Blood, October 15, 2003; 102(8): 2819 - 2827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chuang-Tsai, T. H. Sisson, N. Hattori, C. G. Tsai, N. M. Subbotina, K. E. Hanson, and R. H. Simon Reduction in Fibrotic Tissue Formation in Mice Genetically Deficient in Plasminogen Activator Inhibitor-1 Am. J. Pathol., August 1, 2003; 163(2): 445 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lambert, C. Munaut, P. Carmeliet, R. D. Gerard, P. J. Declerck, A. Gils, C. Claes, J.-M. Foidart, A. Noel, and J.-M. Rakic Dose-Dependent Modulation of Choroidal Neovascularization by Plasminogen Activator Inhibitor Type I: Implications for Clinical Trials Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2791 - 2797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Collen, R. Hanemaaijer, F. Lupu, P. H. A. Quax, N. van Lent, J. Grimbergen, E. Peters, P. Koolwijk, and V. W. M. van Hinsbergh Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix Blood, March 1, 2003; 101(5): 1810 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Gutierrez, M. Suckow, J. Lawler, V. A. Ploplis, and F. J. Castellino Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APCMin/+ mouse model Carcinogenesis, February 1, 2003; 24(2): 199 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Han, J. Leng, D. Bian, C. Mahanivong, K. A. Carpenter, Z. K. Pan, J. Han, and S. Huang Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells J. Biol. Chem., December 6, 2002; 277(50): 48379 - 48385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Palumbo, J. M. Potter, L. S. Kaplan, K. Talmage, D. G. Jackson, and J. L. Degen Spontaneous Hematogenous and Lymphatic Metastasis, but not Primary Tumor Growth or Angiogenesis, Is Diminished in Fibrinogen-deficient Mice Cancer Res., December 1, 2002; 62(23): 6966 - 6972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Binder, G. Christ, F. Gruber, N. Grubic, P. Hufnagl, M. Krebs, J. Mihaly, and G. W. Prager Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles Physiology, April 1, 2002; 17(2): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. DEVY, S. BLACHER, C. GRIGNET-DEBRUS, K. BAJOU, V. MASSON, R. D. GERARD, A. GILS, G. CARMELIET, P. CARMELIET, P. J. DECLERCK, et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J, February 1, 2002; 16(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Providence, L. A. White, J. Tang, J. Gonclaves, L. Staiano-Coico, and P. J. Higgins Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene J. Cell Sci., January 10, 2002; 115(19): 3767 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Rowland-Goldsmith, H. Maruyama, K. Matsuda, T. Idezawa, M. Ralli, S. Ralli, and M. Korc Soluble Type II Transforming Growth Factor-{beta} Receptor Attenuates Expression of Metastasis-associated Genes and Suppresses Pancreatic Cancer Cell Metastasis Mol. Cancer Ther., January 1, 2002; 1(3): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C.Y. Chan, D. A. Duszczyszyn, F. J. Castellino, and V. A. Ploplis Accelerated Skin Wound Healing in Plasminogen Activator Inhibitor-1-Deficient Mice Am. J. Pathol., November 1, 2001; 159(5): 1681 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Pepper Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1104 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. McMahon, E. Petitclerc, S. Stefansson, E. Smith, M. K. K. Wong, R. J. Westrick, D. Ginsburg, P. C. Brooks, and D. A. Lawrence Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis J. Biol. Chem., August 31, 2001; 276(36): 33964 - 33968. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
